Sanofi to buy Colombian drugmaker Genfar
(Reuters) - Giant French pharmaceutical maker Sanofi SA said Tuesday it would buy Colombian drugmaker Genfar to expand its product portfolio in South America.
Genfar is Colombia's second-largest manufacturer of generic drugs with sales of $133 million last year, of which 30 percent was generated outside the country, Sanofi said in a statement announcing the purchase.
"Sanofi has a unique opportunity to strengthen its presence in Latin America through a large portfolio of affordable pharmaceuticals in a broad range of markets," the company's Latin America chief Heraldo Marchezini said in the statement.
Financial terms were not disclosed.
(Reporting by Laurence Frost; Editing by Gerald E. McCormick)
NEW YORK - U.S. stocks finished mostly flat on Thursday as investors paused after a rally in the previous session, though the Dow closed at its second record high in a row. | Video
WASHINGTON - Start-up companies will be able to raise much more capital through certain public stock deals without facing costly regulatory burdens under a proposal announced by U.S. securities regulators on Wednesday.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.